High materiality7/10
BioMarin price target raised to $109 from $105 at Raymond James
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst Raymond James raises BMRN target to 109, with current price around 65.39, signaling strong upside potential.
- Target hike implies meaningful upside from current levels.
Key facts
- 01
Target: $109
- 02
Posted price: $65.39
- 03
Analyst firm: Raymond James
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.